Norfloxacin exhibits negligible serum concentrations after repeated conjunctival instillation in children.
F
F
Drago
C
C
La Manna
V
V
Marino
A
A
Marino
I
I
Emmi
A
A
Reibaldi
D000293:Adolescent; D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood*; D002648:Child; D002675:Child, Preschool; D003228:Conjunctiva; D003234:Conjunctivitis, Bacterial / Q000097:blood* / Q000188:drug therapy*; D004333:Drug Administration Routes; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009643:Norfloxacin / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood*; D009883:Ophthalmic Solutions
D000890:Anti-Infective Agents; D009883:Ophthalmic Solutions; D009643:Norfloxacin